Point72 Middle East FZE’s Zymeworks ZYME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-10,437
Closed -$108K 1386
2023
Q4
$108K Buy
+10,437
New +$83.2K ﹤0.01% 1172
2023
Q2
Sell
-6,596
Closed -$59.6K 2129
2023
Q1
$59.6K Buy
+6,596
New +$57.5K ﹤0.01% 1234

Other funds holding ZYME

Point72 Middle East FZE's ZYME Position: Q1 2024 in Review

Point72 Middle East FZE sold out of Zymeworks (ZYME) in Q1 2024, closing a stake of 10,437 shares — an estimated $108K sold.

Point72 Middle East FZE first reported a position in ZYME in Q1 2023 and held it in 2 quarters. The position peaked at $108K in Q4 2023. 171 funds tracked by Wall St. Rank hold ZYME as of Q1 2024.

  • Point72 Middle East FZE reported no remaining Zymeworks position as of Q1 2024 after selling out during the quarter.
  • Point72 Middle East FZE sold 10,437 Zymeworks shares in Q1 2024, an estimated $108K.
  • Point72 Middle East FZE first reported a position in Zymeworks in Q1 2023 and held it in 2 quarters.
  • Point72 Middle East FZE's Zymeworks position peaked at $108K in Q4 2023.
  • 171 funds tracked by Wall St. Rank held Zymeworks as of Q1 2024.

Based on Point72 Middle East FZE's 13F filing for Q1 2024.